1. Home
  2. LITB vs ICCC Comparison

LITB vs ICCC Comparison

Compare LITB & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LightInTheBox Holding Co. Ltd.

LITB

LightInTheBox Holding Co. Ltd.

N/A

Current Price

$2.68

Market Cap

48.4M

ML Signal

N/A

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$6.52

Market Cap

55.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LITB
ICCC
Founded
2007
1982
Country
Singapore
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.4M
55.5M
IPO Year
2013
1995

Fundamental Metrics

Financial Performance
Metric
LITB
ICCC
Price
$2.68
$6.52
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.0K
15.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
65.33
EPS
N/A
0.20
Revenue
N/A
$26,493,169.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$10.96
$32.05
Revenue Growth
N/A
51.64
52 Week Low
$0.92
$4.32
52 Week High
$4.17
$7.60

Technical Indicators

Market Signals
Indicator
LITB
ICCC
Relative Strength Index (RSI) 46.62 50.06
Support Level $2.39 $5.72
Resistance Level $2.98 $6.91
Average True Range (ATR) 0.21 0.25
MACD -0.02 -0.01
Stochastic Oscillator 13.46 34.48

Price Performance

Historical Comparison
LITB
ICCC

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Share on Social Networks: